Ischemic Stroke Clinical Trials in Atlanta, Georgia

5 studies are recruiting for ischemic stroke in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

    This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limi…

    Stage
    Phase 2
    Ages
    18 to 90
    Site
    Emory University/Grady Memorial Hospital, Atlanta, Georgia
    Locations
    86 in total
    Run by
    DiaMedica Therapeutics Inc

    See if you can join NCT05065216 on ClinicalTrials.gov

  2. Strategy for Improving Stroke Treatment Response

    SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Grady Memorial Hospital, Atlanta, Georgia
    Locations
    52 in total
    Run by
    Translational Sciences, Inc.

    See if you can join NCT05948566 on ClinicalTrials.gov

  3. CTSN Embolic Protection Trial

    This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

    Stage
    Not phased
    Ages
    60 and older
    Site
    Emory University, Atlanta, Georgia
    Locations
    28 in total
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT06027788 on ClinicalTrials.gov

  4. Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe

    A phase III, randomized, multi-center, investigational, open label clinical trial that will examine whether treatment with endovascular thrombectomy is superior to standard medical therapy alone in patients who suffer a Distal Medium Vessel Occlusion Ischemic Stroke within 12 hours from time last s…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Grady Health System, Atlanta, Georgia
    Locations
    4 in total
    Run by
    Raul Nogueira

    See if you can join NCT05983757 on ClinicalTrials.gov

  5. StrokeNet Thrombectomy Endovascular Platform

    STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Grady Memorial Hospital, Atlanta, Georgia
    Locations
    41 in total
    Run by
    Medical University of South Carolina

    See if you can join NCT06289985 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.